TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Swedish Orphan Biovitrum International AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 15,985 | 17,057 | 25,171 |
Financial expenses | 65,689 | 70,958 | 73,693 |
Earnings before taxes | -63,814 | -108,407 | -65,335 |
EBITDA | 876 | -22,213 | 24,128 |
Total assets | 4,014,697 | 4,207,945 | 4,194,461 |
Current assets | 282,139 | 137,828 | 36,733 |
Current liabilities | 9,956 | 11,806 | 39,334 |
Equity capital | 824,957 | 782,902 | 679,977 |
- share capital | 416 | 452 | 461 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 20.5% | 18.6% | 16.2% |
Turnover per employee | |||
Profit as a percentage of turnover | -399.2% | -635.6% | -259.6% |
Return on assets (ROA) | 0.0% | -0.9% | 0.2% |
Current ratio | 2833.9% | 1167.4% | 93.4% |
Return on equity (ROE) | -7.7% | -13.8% | -9.6% |
Change turnover | 309 | -7,637 | -7,696 |
Change turnover % | 2% | -31% | -23% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.